Postpartum depression: psychoneuroimmunological underpinnings and treatment
George Anderson,1 Michael Maes21CRC Clincial Research Centre/Communications, Glasgow, Scotland; 2Department of Psychiatry, Chulalongkorn University, Bangkok, ThailandAbstract: Postpartum depression (PPD) is common, occurring in 10%–15% of women. Due to concerns about teratogenicity of...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0f7d2b9972f049ce8cf55e9e5ce04948 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:0f7d2b9972f049ce8cf55e9e5ce04948 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:0f7d2b9972f049ce8cf55e9e5ce049482021-12-02T06:23:20ZPostpartum depression: psychoneuroimmunological underpinnings and treatment1176-63281178-2021https://doaj.org/article/0f7d2b9972f049ce8cf55e9e5ce049482013-02-01T00:00:00Zhttp://www.dovepress.com/postpartum-depression-psychoneuroimmunological-underpinnings-and-treat-a12280https://doaj.org/toc/1176-6328https://doaj.org/toc/1178-2021George Anderson,1 Michael Maes21CRC Clincial Research Centre/Communications, Glasgow, Scotland; 2Department of Psychiatry, Chulalongkorn University, Bangkok, ThailandAbstract: Postpartum depression (PPD) is common, occurring in 10%–15% of women. Due to concerns about teratogenicity of medications in the suckling infant, the treatment of PPD has often been restricted to psychotherapy. We review here the biological underpinnings to PPD, suggesting a powerful role for the tryptophan catabolites, indoleamine 2,3-dixoygenase, serotonin, and autoimmunity in mediating the consequences of immuno-inflammation and oxidative and nitrosative stress. It is suggested that the increased inflammatory potential, the decreases in endogenous anti-inflammatory compounds together with decreased omega-3 poly-unsaturated fatty acids, in the postnatal period cause an inflammatory environment. The latter may result in the utilization of peripheral inflammatory products, especially kynurenine, in driving the central processes producing postnatal depression. The pharmacological treatment of PPD is placed in this context, and recommendations for more refined and safer treatments are made, including the better utilization of the antidepressant, and the anti-inflammatory and antioxidant effects of melatonin.Keywords: SSRI, kynurenine, IDO, TDO, melatoninAnderson GMaes MDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2013, Iss default, Pp 277-287 (2013) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 |
spellingShingle |
Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Anderson G Maes M Postpartum depression: psychoneuroimmunological underpinnings and treatment |
description |
George Anderson,1 Michael Maes21CRC Clincial Research Centre/Communications, Glasgow, Scotland; 2Department of Psychiatry, Chulalongkorn University, Bangkok, ThailandAbstract: Postpartum depression (PPD) is common, occurring in 10%–15% of women. Due to concerns about teratogenicity of medications in the suckling infant, the treatment of PPD has often been restricted to psychotherapy. We review here the biological underpinnings to PPD, suggesting a powerful role for the tryptophan catabolites, indoleamine 2,3-dixoygenase, serotonin, and autoimmunity in mediating the consequences of immuno-inflammation and oxidative and nitrosative stress. It is suggested that the increased inflammatory potential, the decreases in endogenous anti-inflammatory compounds together with decreased omega-3 poly-unsaturated fatty acids, in the postnatal period cause an inflammatory environment. The latter may result in the utilization of peripheral inflammatory products, especially kynurenine, in driving the central processes producing postnatal depression. The pharmacological treatment of PPD is placed in this context, and recommendations for more refined and safer treatments are made, including the better utilization of the antidepressant, and the anti-inflammatory and antioxidant effects of melatonin.Keywords: SSRI, kynurenine, IDO, TDO, melatonin |
format |
article |
author |
Anderson G Maes M |
author_facet |
Anderson G Maes M |
author_sort |
Anderson G |
title |
Postpartum depression: psychoneuroimmunological underpinnings and treatment |
title_short |
Postpartum depression: psychoneuroimmunological underpinnings and treatment |
title_full |
Postpartum depression: psychoneuroimmunological underpinnings and treatment |
title_fullStr |
Postpartum depression: psychoneuroimmunological underpinnings and treatment |
title_full_unstemmed |
Postpartum depression: psychoneuroimmunological underpinnings and treatment |
title_sort |
postpartum depression: psychoneuroimmunological underpinnings and treatment |
publisher |
Dove Medical Press |
publishDate |
2013 |
url |
https://doaj.org/article/0f7d2b9972f049ce8cf55e9e5ce04948 |
work_keys_str_mv |
AT andersong postpartumdepressionpsychoneuroimmunologicalunderpinningsandtreatment AT maesm postpartumdepressionpsychoneuroimmunologicalunderpinningsandtreatment |
_version_ |
1718399916477251584 |